Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Acrivon Therapeutics, Inc. - Common Stock (NQ:ACRV)

1.520 -0.030 (-1.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 884,044
Open 1.550
Bid (Size) 1.510 (19)
Ask (Size) 1.520 (6)
Prev. Close 1.550
Today's Range 1.460 - 1.570
52wk Range 1.050 - 10.00
Shares Outstanding 21,925,982
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
In today's session, these stocks are experiencing unusual volume.
Let's have a look at the stocks with an unusual volume in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-73.3%
-73.3%
1 Month
+16.0%
+16.0%
3 Month
+26.7%
+26.7%
6 Month
-72.1%
-72.1%
1 Year
-83.5%
-83.5%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Friday's after hours session: top gainers and losers
Via Chartmill
Acrivon Posts Narrower Loss in Q2
Via The Motley Fool
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
From Acrivon Therapeutics, Inc
Via GlobeNewswire
Acrivon Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights
From Acrivon Therapeutics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Acrivon Therapeutics to Reveal the Molecular Mechanisms Driving Strong Single-Agent Activity of ACR-2316, its AP3-Enabled Clinical Stage WEE1/PKMYT1 Inhibitor, at the AACR Annual Meeting 2025
From Acrivon Therapeutics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Top stock movements in today's session.
Via Chartmill
Tuesday's session: top gainers and losers
Via Chartmill
Acrivon Therapeutics Appoints World-Renowned Oncology Key Opinion Leader and Clinical Investigator Mansoor Raza Mirza, M.D., as Chief Medical Officer
From Acrivon Therapeutics, Inc
Via GlobeNewswire
On Wednesday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
These stocks have an unusual volume in today's session
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results
From Acrivon Therapeutics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Gains Over 1%; Cintas Shares Jump After Q3 Earnings
Via Benzinga
Nasdaq Down 1%; Dollar Tree To Sell Family Dollar Business For $1 Billion
Via Benzinga
Acrivon Therapeutics to Host Corporate R&D Event to Provide AP3 Platform Capabilities and Clinical ACR-368 and ACR-2316 Program Updates
From Acrivon Therapeutics, Inc
Via GlobeNewswire
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer
From Acrivon Therapeutics, Inc
Via GlobeNewswire

Frequently Asked Questions

Is Acrivon Therapeutics, Inc. - Common Stock publicly traded?
Yes, Acrivon Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Acrivon Therapeutics, Inc. - Common Stock trade on?
Acrivon Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Acrivon Therapeutics, Inc. - Common Stock?
The ticker symbol for Acrivon Therapeutics, Inc. - Common Stock is ACRV on the Nasdaq Stock Market
What is the current price of Acrivon Therapeutics, Inc. - Common Stock?
The current price of Acrivon Therapeutics, Inc. - Common Stock is 1.520
When was Acrivon Therapeutics, Inc. - Common Stock last traded?
The last trade of Acrivon Therapeutics, Inc. - Common Stock was at 09/12/25 04:00 PM ET
What is the market capitalization of Acrivon Therapeutics, Inc. - Common Stock?
The market capitalization of Acrivon Therapeutics, Inc. - Common Stock is 33.33M
How many shares of Acrivon Therapeutics, Inc. - Common Stock are outstanding?
Acrivon Therapeutics, Inc. - Common Stock has 33M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.